Pediatric Blood & Cancer · 2011 · 34 citations · 21 references
MedicineHematologyPediatricsPediatric HematologyStem Cell TransplantationTransfusion MedicineAnemiaDonor MatchingHla MatchingPediatric TransplantationSickle Cell DiseaseTransfusion SupportAcute Chest SyndromeFull SiblingsHla Antigen MatchingHuman Leukocyte Antigen TestingSibling Donor MatchingSickle Cell AnemiaTransfusion IndicationsTransplantation
BACKGROUND: Bone marrow transplantation (BMT) using human leukocyte antigen (HLA)-matched sibling donors can be curative for children with sickle cell anemia (SCA). However, minimal data exist regarding availability of HLA-identical matched siblings for transplant-eligible children, and family interest in pursuing transplantation. METHODS: We retrospectively analyzed a pediatric SCA cohort receiving chronic transfusions between July 2004 and January 2011. Data were analyzed regarding the number of full siblings and half-siblings, availability, and family interest in HLA testing the full siblings, and interest in proceeding with HLAmatched transplantation. RESULTS: Among 113 patients, 46 (41%) had at least 1 full sibling and 40 (35%) had an unaffected full sibling who could serve as a BMT donor. The families of 23 of these patients (58%) agreed to HLA-type sibling, 8 of whom (35%) were matched. Transfusion indications for families agreeing to HLA typing included stroke (46%) abnormal TCD (29%), acute chest syndrome (21%), and other CNS reasons (4%). Common reasons to decline HLA typing or transplantation included fear of the process, toxicities of the procedure, and comfort with current quality of life on transfusions. Only 8 of 113 (7%) were eligible for matched BMT, and only 3 (3%) underwent HLA-matched transplantation. Two unmatched children received haploidentical transplantation. CONCLUSIONS: Most families of children with SCA on chronic transfusions choose to proceed with HLA typing. However, when a matched sibling was identified, most families declined to proceed with matched-sibling transplantation. Discussing BMT as a treatment option, offering HLA typing and identifying barriers may improve acceptance of this treatment modality.
21
Bone Marrow Transplantation for Sickle Cell Disease
Mark C. Walters, Melinda Patience, Wendy M. Leisenring et al. · New England Journal of Medicine · 1996 · 630 citations
Medicine, Hematology, Pediatrics +7
Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease
Françoise Bernaudin, Gèrard Socié, Mathieu Kuentz et al. · Blood · 2007 · 502 citations · Full text
Medicine, Hematology, Cell Therapy +12
Bone-Marrow Transplantation in a Patient with Sickle-Cell Anemia
F. Leonard Johnson, A. Thomas Look, Jon P. Gockerman et al. · New England Journal of Medicine · 1984 · 317 citations
Medicine, Genetics, Hematology +11